Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Mohamed KHARFAN-DABAJA"'
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTBackground One major limitation for broader applicability of allogeneic hematopoietic cell transplantation (allo-HCT) in the past was the lack of HLA-matched histocompatible donors. Preclinical mouse studies using T-cell depleted haploidentic
Externí odkaz:
https://doaj.org/article/0d5342cfd0f34d9eab336b1de19c2b48
Autor:
Mark Gurney, Hassan Alkhateeb, Syed Shah, Radhika Bansal, Matthew Hathcock, Allison Rosenthal, Mohamed Kharfan-Dabaja, Taxiarchis Kourelis, Mrinal Patnaik, Dong Chen, Aref Al-Kali, Saad Kenderian, Yi Lin, Mithun Shah
Publikováno v:
HemaSphere, Vol 7, p e6718317 (2023)
Externí odkaz:
https://doaj.org/article/1f1d7550d67a4c5880e20419c56b3ec0
Autor:
Hassan B. Alkhateeb, Razan Mohty, Patricia Greipp, Radhika Bansal, Matthew Hathcock, Allison Rosenthal, Hemant Murthy, Mohamed Kharfan-Dabaja, Jose C. Bisneto Villasboas, Nora Bennani, Stephen M. Ansell, Mrinal M. Patnaik, Mark R. Litzow, Rong He, Dong Chen, Aref Al-Kali, Saad S. Kenderian, Yi Lin, Mithun Vinod Shah
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 7, Pp 1-5 (2022)
Externí odkaz:
https://doaj.org/article/7de77bbecbfe4425ac445e6691979e5a
Autor:
Ahmad Ghorab, Aref Al-Kali, Michelle Elliot, Naseema Gangat, Hasan Alkhateeb, Mithun Shah, Yuanhang Liu, Cecilia Arana Yi, Hemant Murthy, Mohamed Kharfan-Dabaja, Ayalew Tefferi, Mrinal Patnaik, Mark Litzow, Talha Badar
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 6, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/9dab5b2de29f4d40a109c8a34bd12032
Autor:
Ali Bazarbachi, Gesine Bug, Frederic Baron, Eolia Brissot, Fabio Ciceri, Iman Abou Dalle, Hartmut Döhner, Jordi Esteve, Yngvar Floisand, Sebastian Giebel, Maria Gilleece, Norbert-Claude Gorin, Elias Jabbour, Mahmoud Aljurf, Hagop Kantarjian, Mohamed Kharfan-Dabaja, Myriam Labopin, Francesco Lanza, Florent Malard, Zinaida Peric, Thomas Prebet, Farhad Ravandi, Annalisa Ruggeri, Jaime Sanz, Christoph Schmid, Roni Shouval, Alexandros Spyridonidis, Jurjen Versluis, Norbert Vey, Bipin N Savani, Arnon Nagler, Mohamad Mohty
Publikováno v:
Haematologica, Vol 105, Iss 6 (2020)
The FMS-like tyrosine kinase 3 (FLT3) gene is mutated in 25-30% of patients with acute myeloid leukemia (AML). Because of the poor prognosis associated with FLT3-internal tandem duplication mutated AML, allogeneic hematopoietic stem-cell transplantat
Externí odkaz:
https://doaj.org/article/5008f9a4eb4f47229b08281560fa9180
Autor:
Brian C. Betts, Joseph Pidala, Jongphil Kim, Asmita Mishra, Taiga Nishihori, Lia Perez, Jose Leonel Ochoa-Bayona, Farhad Khimani, Kelly Walton, Ryan Bookout, Michael Nieder, Divis K. Khaira, Marco Davila, Melissa Alsina, Teresa Field, Ernesto Ayala, Frederick L. Locke, Marcie Riches, Mohamed Kharfan-Dabaja, Hugo Fernandez, Claudio Anasetti
Publikováno v:
Haematologica, Vol 102, Iss 5 (2017)
Graft-versus-host disease (GvHD) remains a major cause of transplant-related mortality. Interleukin-2 (IL-2) plus sirolimus (SIR) synergistically reduces acute GvHD in rodents and promotes regulatory T cells. This phase II trial tested the hypothesis
Externí odkaz:
https://doaj.org/article/59183ba5b9594f8b90b610eba3642511
Autor:
Hanna J. Khoury, Tao Wang, Michael T. Hemmer, Daniel Couriel, Amin Alousi, Corey Cutler, Mahmoud Aljurf, Joseph H. Antin, Mouhab Ayas, Minoo Battiwalla, Jean-Yves Cahn, Mitchell Cairo, Yi-Bin Chen, Robert Peter Gale, Shahrukh Hashmi, Robert J. Hayashi, Madan Jagasia, Mark Juckett, Rammurti T. Kamble, Mohamed Kharfan-Dabaja, Mark Litzow, Navneet Majhail, Alan Miller, Taiga Nishihori, Muna Qayed, Helene Schoemans, Harry C. Schouten, Gerard Socie, Jan Storek, Leo Verdonck, Ravi Vij, William A. Wood, Lolie Yu, Rodrigo Martino, Matthew Carabasi, Christopher Dandoy, Usama Gergis, Peiman Hematti, Melham Solh, Kareem Jamani, Leslie Lehmann, Bipin Savani, Kirk R. Schultz, Baldeep M. Wirk, Stephen Spellman, Mukta Arora, Joseph Pidala
Publikováno v:
Haematologica, Vol 102, Iss 5 (2017)
A cute graft-versus-host disease remains a major threat to a successful outcome after allogeneic hematopoietic cell transplantation. While improvements in treatment and supportive care have occurred, it is unknown whether these advances have resulted
Externí odkaz:
https://doaj.org/article/1cf6f142c7dc4c4fbaa4220d5397ff37
Autor:
Mohamed Kharfan-Dabaja, Mohamed Baydoun, Zaher Otrock, Samar Okaily, Rita Nehme, Racha Abu-Chahine, Ali Hamdan, Samar Noureddine, Souha Kanj, Zeina Kanafani, Ali Bazarbachi
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 5, Iss 1, Pp e2013015-e2013015 (2013)
Hematopoietic stem cells are usually transfused through a central venous catheter (CVC), which also facilitates administration of medications and intravenous fluids. We had observed high rate of catheter-related blood-stream infection (CR-BSI) at our
Externí odkaz:
https://doaj.org/article/46b17ab8d72d4fd2ad90020e3b69a93f
Autor:
Kazem Zibara, Rima Hamdan, Leila Dib, Steen Sindet-Pedersen, Mohamed Kharfan-Dabaja, Ali Bazarbachi, Marwan El-Sabban
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40140 (2012)
Hematopoietic stem cells (HSC) derived from cord blood (CB), bone marrow (BM), or mobilized peripheral blood (PBSC) can differentiate into multiple lineages such as lymphoid, myeloid, erythroid cells and platelets. The local microenvironment is criti
Externí odkaz:
https://doaj.org/article/263f37c1c11d4882ad60df0b51f9922b
Autor:
Ayman Saad, Alison Loren, Javier Bolaños-Meade, George Chen, Daniel Couriel, Antonio Di Stasi, Areej El-Jawahri, Hany Elmariah, Sherif Farag, Krishna Gundabolu, Jonathan Gutman, Vincent Ho, Rasmus Hoeg, Mitchell Horwitz, Joe Hsu, Adetola Kassim, Mohamed Kharfan Dabaja, John Magenau, Thomas Martin, Marco Mielcarek, Jonathan Moreira, Ryotaro Nakamura, Yago Nieto, Cameron Ninos, Caspian Oliai, Seema Patel, Brion Randolph, Mark Schroeder, Dimitrios Tzachanis, Asya Nina Varshavsky-Yanovsky, Madhuri Vusirikala, Frankie Algieri, Lenora A. Pluchino
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:108-115
The NCCN Guidelines for Hematopoietic Cell Transplantation (HCT) provide an evidence- and consensus-based approach for the use of autologous and allogeneic HCT in the management of malignant diseases in adult patients. HCT is a potentially curative t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7136caf9299cb573b2f0c96b5fb18cbb
https://doi.org/10.6004/jnccn.2023.0007
https://doi.org/10.6004/jnccn.2023.0007